Unlike other available blood and urine tests, the miR Sentinel Prostate Cancer Test characterizes the entire prostate, allowing for more accurate results. If molecular evidence of aggressive prostate cancer is present, the results classify a patient’s condition into categories describing the risk classification of the tumor.
The prostate naturally releases molecules into urine, including several different kinds of genetic material that vary depending on the presence and severity of prostate cancer. We extract and measure these fragments, known as small non-coding RNAs, using gene expression technology and a proprietary algorithm. The miR Sentinel Prostate Cancer Test is a standalone test – it does not rely on PSA or biopsy material.
This result indicates that the patient presents No Molecular Evidence of Prostate Cancer.
This result indicates that the patient presents Molecular Evidence of Low-Risk For Aggressive Prostate Cancer
This result indicates that the patient presents Molecular Evidence of Elevated-Risk For Aggressive Prostate Cancer
miR Scientific’s unique sncRNA extraction and interrogation techniques coupled with an advanced proprietary algorithm will allow physicians to confidently detect and classify prostate cancers with just one urine sample, reducing unnecessary prostate cancer diagnostic procedures and treatments.
Book an appointment with your medical provider and request a prescription for the miR Sentinel Prostate Cancer Test™.
Provide a simple urine sample
in your provider’s office
Your provider will receive comprehensive and accurate results--together you will discuss their meaning and next steps.
El resultado será enviado de forma segura al médico que solicitó la prueba, ya sea mediante fax seguro o correo electrónico.
Estará disponible comercialmente en la mayoría de los estados de EE. UU. y en Puerto Rico a principios de 2025. Actualmente, no está disponible en Nueva York.
El kit de recolección de MiRNA Scientific puede ser solicitado por un proveedor de salud mediante vía telefónica, llamando a Servicio al Cliente: 1 (940) 647-7368.
MiRNA Scientific se encuentra trabajando con aseguradoras de salud y Medicare en EE. UU. y Puerto Rico, sin embargo, es posible que la prueba no esté cubierta. Presentaremos una reclamación por usted, y someteremos cualquier proceso apelativo, si aplica. De ser necesario, los pacientes pueden solicitar participación al programa de asistencia miR Access, y proceder con el pago de cualquier saldo restante mediante tarjeta de crédito.
Actualmente, solo está disponible a través de un proveedor de salud. Hable con su médico sobre las opciones de prueba disponibles.
We're here to help! Visit our support center for FAQs and options to connect with a miR Sentinel expert directly.
SUPPORT CENTER
